|
 
- 积分
- 770
- 威望
- 770
- 包包
- 96
|
c1 b) f7 x/ o/ \% t# G5 F/ u1.Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
* \; {, j' P% t- x! ?/ Lhttp://www.jci.org/articles/view/72992* j' A) o" c; y0 @" E/ l1 f, J4 s
2.Reduction in CD4 Central Memory T-cell subset in Co-Stimulation Modulator Abatacept-Treated Patients with Recent-Onset Type 1 Diabetes is Associated with Slower C-Peptide Decline4 l- [& C5 ?0 |; c6 q9 W C8 j% T
http://diabetes.diabetesjournals ... /db14-0047.abstract4 {8 ?( ^8 T/ N: L6 d. ^6 C X
3.Cdkn2a/p16Ink4a Regulates Fasting-Induced Hepatic Gluconeogenesis Through the PKA-CREB-PGC1α Pathway
9 Z* E3 C3 b: s! I2 b- R& q8 ahttp://diabetes.diabetesjournals ... /3199.full.pdf+html
1 W* Z( o3 i+ z3 J0 d) i! @0 \4.Cyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α
. K0 |1 T3 P- y9 ~8 _& P% g: jhttp://diabetes.diabetesjournals ... /3266.full.pdf+html- V* z1 b' V9 A3 {
5.Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline# o4 B* e3 [# n' N' A! a$ T
http://diabetes.diabetesjournals ... /3449.full.pdf+html |
|
发表于 2014-11-8 17:35
